IPSEN PORTUGAL-PRODUTOS FARMACEUTICOS SA. secures contract for Direct Adjustment For Acquisition Of T1140 - Triptorrelin (Inj Sun Powder) [01 Mg/Ml; 1 Ml; Frs] And T202 - Triptorrelin (Powder For Susp Inj) [3.75Mg; Frs/ Syringe] To Meet Healthcare Needs

Portugal, Nov. 24 -- Portugal based IPSEN PORTUGAL-PRODUTOS FARMACEUTICOS SA. has secured contract from Unidade Local De Saude De Santo Antonio, E. P. E. for Direct Adjustment For Acquisition Of T1140 - Triptorrelin (Inj Sun Powder) [01 Mg/Ml; 1 Ml; Frs] And T202 - Triptorrelin (Powder For Susp Inj) [3.75Mg; Frs/ Syringe] To Meet Healthcare Needs. The value of the contract is worth 209304 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....